01 5Sumitomo Dainippon Pharma Co., Ltd.
02 6Sumitomo Pharma Co., Ltd.
01 1No Action Indicated
02 10Voluntary Action Indicated
01 12025-08-07
02 12019-11-22
03 12019-04-16
04 12018-07-27
05 12017-02-17
06 12016-09-09
07 12014-09-12
08 12013-11-01
09 12012-02-24
10 12012-02-23
11 12010-07-30
01 5Oita
02 6Suzuka
01 11Japan
District Decision : Voluntary Action Indicated
Inspection End Date : 2025-08-07
City : Suzuka
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2025-08-07
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-11-22
City : Suzuka
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-11-22
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-04-16
City : Oita
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-04-16
District Decision : No Action Indicated
Inspection End Date : 2018-07-27
City : Suzuka
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2018-07-27
District Decision : Voluntary Action Indicated
Inspection End Date : 2017-02-17
City : Oita
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2017-02-17
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-09-09
City : Suzuka
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-09-09
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-09-12
City : Oita
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-09-12
District Decision : Voluntary Action Indicated
Inspection End Date : 2013-11-01
City : Suzuka
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2013-11-01
District Decision : Voluntary Action Indicated
Inspection End Date : 2012-02-24
City : Oita
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2012-02-24
District Decision : Voluntary Action Indicated
Inspection End Date : 2012-02-23
City : Suzuka
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2012-02-23
Sumitomo Pharma is a supplier offers 16 products (APIs, Excipients or Intermediates).
Find Lurasidone Hydrochloride bulk with DMF offered by Sumitomo Pharma
Find Zonisamide bulk with DMF offered by Sumitomo Pharma
Find Amrubicin bulk offered by Sumitomo Pharma
Find Droxidopa bulk offered by Sumitomo Pharma
Find Enoxacin bulk offered by Sumitomo Pharma
Find Meropenem bulk offered by Sumitomo Pharma
Find Ranirestat bulk offered by Sumitomo Pharma
Find Rimacalib bulk offered by Sumitomo Pharma
Find Sm-216601 bulk offered by Sumitomo Pharma
Find Smp 797 bulk offered by Sumitomo Pharma
Find Sparfloxacin bulk offered by Sumitomo Pharma
Find SMP-986 bulk offered by Sumitomo Pharma
Find SMP-028 bulk offered by Sumitomo Pharma
Find Blonanserin bulk offered by Sumitomo Pharma
Find Mosapride Citrate bulk offered by Sumitomo Pharma
Find Sodium Hyaluronate bulk offered by Sumitomo Pharma
